Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSXS in moderate to severe atopic dermatitis
NCT02595073Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing DSXS topical product with Placebo topical product (2 arms). Primary endpoint: The Number of Patients in Each Treatment Group That Have Clinical Success at 28 days. Started Sep 2015; status: completed.
02
Drugs
desoximetasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02595073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595073.